Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Country / region: Taiwan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20091
20111
20162
20174
20184
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Hoffmann-La Roche2
Amgen1
AstraZeneca1
Bristol-Myers Squibb1
Eli Lilly and Company1
Exelixis1
GlaxoSmithKline1
Impact Therapeutics, Inc.1
Ipsen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma19
Carcinoma, Non-Small-Cell Lung5
Neoplasms5
Carcinoma, Hepatocellular3
Ovarian Neoplasms3
Breast Neoplasms2
Carcinoma, Merkel Cell2
Cholangiocarcinoma2
Melanoma2
Mesothelioma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.